We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Improved technology satisfaction and sleep quality with Medtronic MiniMed® Advanced Hybrid Closed-Loop delivery compared to predictive low glucose suspend in people with Type 1 Diabetes in a randomized crossover trial.
- Authors
Wheeler, Benjamin J.; Collyns, Olivia J.; Meier, Renee A.; Betts, Zara L.; Frampton, Chris; Frewen, Carla M.; Galland, Barbara; Hewapathirana, Niranjala M.; Jones, Shirley D.; Chan, Denis S. H.; Roy, Anirban; Grosman, Benyamin; Kurtz, Natalie; Shin, John; Vigersky, Robert A.; de Bock, Martin I.
- Abstract
Background: Automated insulin delivery aims to lower treatment burden and improve quality of life as well as glycemic outcomes. Methods: We present sub-study data from a dual-center, randomized, open-label, two-sequence crossover study in automated insulin delivery naïve users, comparing Medtronic MiniMed® Advanced Hybrid Closed-Loop (AHCL) to Sensor Augmented Pump therapy with Predictive Low Glucose Management (SAP + PLGM). At the end of each 4-week intervention, impacts on quality of life, sleep and treatment satisfaction were compared using seven age-appropriate validated questionnaires given to patients or caregivers. Results: 59/60 people completed the study (mean age 23.3 ± 14.4yrs). Statistically significant differences favoring AHCL were demonstrated in several scales (data shown as mean ± SE). In adults (≥ 18yrs), technology satisfaction favored AHCL over PLGM as shown by a higher score in the DTSQs during AHCL (n = 28) vs SAP + PLGM (n = 29) (30.9 ± 0.7 vs 27.9 ± 0.7, p = 0.004) and DTSQc AHCL (n = 29) vs SAP + PLGM (n = 30) (11.7 ± 0.9 vs 9.2 ± 0.8, p = 0.032). Adolescents (aged 13–17yrs) also showed a higher DTSQc score during AHCL (n = 16) versus SAP + PLGM (n = 15) (14.8 ± 0.7 vs 12.1 ± 0.8, p = 0.024). The DTQ "change" score (n = 59) favored AHCL over SAP + PLGM (3.5 ± 0.0 vs 3.3 ± 0.0, p < 0.001). PSQI was completed in those > 16 years (n = 36) and demonstrated improved sleep quality during AHCL vs SAP + PLGM (4.8 ± 0.3 vs 5.7 ± 0.3, p = 0.048) with a total score > 5 indicating poor quality sleep. Conclusion: These data suggest that AHCL compared to SAP + PLGM mode has the potential to increase treatment satisfaction and improve subjective sleep quality in adolescents and adults with T1D.
- Subjects
TYPE 1 diabetes; CROSSOVER trials; INSULIN pumps; PATIENT satisfaction; SUBCUTANEOUS infusions; GLUCOSE; SLEEP
- Publication
Acta Diabetologica, 2022, Vol 59, Issue 1, p31
- ISSN
0940-5429
- Publication type
Article
- DOI
10.1007/s00592-021-01789-5